10-QPeriod: Q1 FY1996

BRISTOL MYERS SQUIBB CO Quarterly Report for Q1 Ended Mar 31, 1996

Filed May 15, 1996For Securities:BMYCELG-RIBMYMP

Summary

Bristol-Myers Squibb Company (BMY) filed its 10-Q quarterly report for the period ending March 30, 1996. As this is an historical filing from 1996, the specific financial and operational details that would typically be found in the full report text are not available in the provided excerpt. The excerpt consists primarily of SEC website navigation and directory listings, rather than the substantive financial statements or management discussion and analysis that investors would rely on for current decision-making. Therefore, a detailed financial analysis is not feasible. Investors interested in BMY's performance around this period would need to access the full 10-Q filing to review crucial information such as revenue trends, profitability metrics, research and development expenditures, debt levels, and any significant events or strategic initiatives that may have been disclosed. Without this data, any insights would be speculative.

Key Highlights

  • 1Filing Date: May 14, 1996
  • 2Reporting Period End Date: March 30, 1996
  • 3Company: Bristol-Myers Squibb Co (BMY)
  • 4Document Type: 10-Q Quarterly Report
  • 5The provided excerpt does not contain the detailed financial statements or narrative required for a comprehensive analysis.
  • 6Access to the full 10-Q filing is necessary to understand the company's financial health and performance for the reported quarter.
  • 7Historical context: This report reflects BMY's financial status in the mid-1990s.

Frequently Asked Questions

Unfortunately, the provided text is a directory listing and does not contain the specific financial statements (income statement, balance sheet, cash flow statement) or the Management's Discussion and Analysis required to determine key financial results such as revenue, net income, earnings per share, or cash flow. Investors would need to access the full 10-Q filing document.

The excerpt provided does not include the narrative sections of the 10-Q report, such as the Management's Discussion and Analysis, where significant business developments, acquisitions, divestitures, or strategic shifts would typically be disclosed. To understand these, the full filing is required.

This 10-Q filing from May 1996 is of historical significance only. It provides a snapshot of Bristol-Myers Squibb's financial and operational status at that specific point in time. It is not relevant for making current investment decisions, as it does not reflect the company's present performance, strategy, or market position.